HEPATITIS D, CHRONIC
Clinical trials for HEPATITIS D, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS D, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat hepatitis d
Disease control OngoingThis study is testing two experimental drugs, VIR-2218 and VIR-3434, in people with chronic hepatitis D virus infection. The goal is to see if these drugs can safely reduce the amount of virus in the blood and improve liver health. About 95 participants will receive different com…
Matched conditions: HEPATITIS D, CHRONIC
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists hunt for clues to stop lifelong hepatitis d drugs
Disease control OngoingThis study aims to find biological markers in the blood or liver that can tell doctors when it might be safe for patients with chronic hepatitis D to stop taking the drug bulevirtide. Researchers will stop treatment in 20 patients whose virus is well-controlled and monitor them f…
Matched conditions: HEPATITIS D, CHRONIC
Phase: NA • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC